[1] GREEN D M，O''DONOGHUE K.A review of reproductive outcomes of women with two consecutive miscarriages and no living child[J].J Obstet Gynaecol，2019，39（6）：816-821.
[2] GAO R，QIN L.Obstetric antiphospholipid syndrome：insights on the diagnosis，treatment，and hot issues[J].Sichuan Da Xue Xue Bao Yi Xue Ban，2024，55（3）：513-520.
[3] VOICU D I，MUNTEANU O，GHERGHICEANU F，et al.Maternal inherited thrombophilia and pregnancy outcomes[J].Exp Ther Med，2020，20（3）：2411-2414.
[4] SHAKER M M，ELARABY N M，SHALABI T A.Association of MTR and MTRR polymorphisms with recurrent pregnancy loss：a case control study[J].Molecular Biology Reports，2024，51（1）：12.
[5] DE JONG P G，KAANDORP S，DI NISIO M，et al.Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia[J].Cochrane Database Syst Rev，2014，2014（7）：Cd004734.
[6] CUGNO M，BORGHI A，GARCOVICH S，et al.Coagulation and skin autoimmunity[J].Front Immunol，2019，10：1407.
[7] CASHMAN D，RACKARD S.Learning through clinical extramural studies：an observational study[J].Ir Vet J，2023，76（1）：10.
[9] PĂULEŢ F P，ŢURCAN N，GHERGHICEANU F，et al.Prognosis of autoimmune thyroid disease associated with hereditary thrombophilia during pregnancy[J].Exp Ther Med，2020，20（3）：2429-2433.
[10] DERBENT A U，YANIK F F，INEGöL GüMüŞ I，et al.Impact of inherited thrombophilias on first and second trimester maternal serum markers for aneuploidy[J].J Matern Fetal Neonatal Med，2012，25（11）：2177-2181.
[11] ALI S A，MOIZ B，SHEIKH L.Association of factor V leiden G1691A and prothrombin gene G20210A mutations with adverse pregnancy outcomes[J].J Pak Med Assoc，2021，71（7）：1780-1784.
[12] GROARKE E M，DULAU-FLOREA A E，KANTHI Y.Thrombotic manifestations of VEXAS syndrome[J].Semin Hematol，2021，58（4）：230-238.
[14] BILLOIR P，MIRANDA S，LEVESQUE H，et al.Hypercoagulability evaluation in antiphospholipid syndrome without anticoagulation treatment with thrombin generation assay：a preliminary study[J].J Clin Med，2021，10（12）：2581.
[15] SCHROTTMAIER W C，ASSINGER A.The Concept of Thromboinflammation[J].Hamostaseologie，2024，44（1）：21-30.
[16] NAPPI F.To gain insights into the pathophysiological mechanisms of the thrombo-inflammatory process in the atherosclerotic plaque[J].Int J Mol Sci，2023，25（1）： 332.
[17] TAO J J，ADURTY S，D''ANGELO D，et al.Management and outcomes of women with antiphospholipid syndrome during pregnancy[J].J Thromb Thrombolysis，2023，55（4）：751-759.
[20] KUTTEH W H，TRIPLETT D A.Thrombophilias and recurrent pregnancy loss[J].Semin Reprod Med，2006，24（1）：54-66.
[21] LI D，ZHENG L，ZHAO D，et al.The role of immune cells in recurrent spontaneous abortion[J].Reprod Sci，2021，28（12）：3303-3315.
[22] ABDOLMOHAMMADI-VAHID S，PASHAZADEH F，POURMOGHADDAM Z，et al.The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure （RIF）：a systematic review and meta-analysis[J].J Reprod Immunol，2019，134-135：28-33.
[23] BRANCH D W.What''s new in obstetric antiphospholipid syndrome[J].Hematology Am Soc Hematol Educ Program，2019，2019（1）：421-425.
